Investor's Business Daily on MSN1d
IBD Stock Of The Day: Meta Tests Key Level After Record-Setting Rally Ends
Meta stock pulled back this week following a record-setting rally, but shares are finding support at their 21-day line.
pharmaphorum3d
The rise and market race of anti-IL23p19 therapies in IBD: How ECCO 2025 readouts will shape the anti-interleukin landscape
The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...
Healio12d
Most patients with IBD ‘still experience significant challenges’ accessing, affording care
Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due ...
MedPage Today12d
Major Heart Risks Similar With Two IBD Drugs in Older Adults
For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...
The American Journal of Managed Care11d
Abstracts Highlight Access Barriers, CV Risks Associated With IBD Care
Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...
clinicalpainadvisor.com3d
Arthralgia, EIMs Linked to Risk for IBD-Related Arthritis in Crohn Disease
Extraintestinal manifestations and arthralgia are significant predictors of IBD-related arthritis among patients with CD, while sacroiliitis was not associated.